Point72 Hong Kong LTD Opti Nose, Inc. Transaction History

Point72 Hong Kong LTD

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$2.35 - $3.16 $458 - $616	-195 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$2.91 - $3.83 $6,128 - $8,065	-2,106 Reduced 91.53%	195 $1,000
Q1 2021 May 17, 2021	SELL	$3.47 - $4.75 $6,905 - $9,452	-1,990 Reduced 46.38%	2,301 $8,000
Q4 2020 Feb 16, 2021	BUY	$3.2 - $4.98 $13,731 - $21,369	4,291 New	4,291 $18,000
Q3 2019 Nov 14, 2019	SELL	$4.75 - $8.38 $631 - $1,114	-133 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$6.4 - $10.94 $851 - $1,455	133 New	133 $1,000
Q4 2018 Feb 14, 2019	SELL	$5.84 - $11.92 $6,570 - $13,410	-1,125 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$12.43 - $29.76 $13,983 - $33,480	1,125 New	1,125 $14,000

88.3M

Ticker OPTN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 83,277,504
Market Cap $42.5M
Description
OptiNose, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists in the United States. The company offers XHANCE, a therapeutic product utilizing its proprietary exhalation delivery system (EDS) that delivers a topically-acting cort...

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

Stay updated on Point72 Hong Kong LTD with notifications on news.